An animal model of Burning Mouth Syndrome (BMS) for assessment of peripheral gamma-aminobutuyric acid A (GABAA) receptors as an analgesic target

Burning Mouth Syndrome (BMS) is a chronic pain syndrome characterised by burning pain in patients with clinically normal oral mucosa (Grushka et al., 2002). The prevalence of BMS increases with age and occurs far more commonly in women, with estimated female to male ratios ranging from 3:1 to 16:...

Full description

Bibliographic Details
Main Author: Tan, Sun Nee
Language:English
Published: University of British Columbia 2013
Online Access:http://hdl.handle.net/2429/43890
id ndltd-LACETR-oai-collectionscanada.gc.ca-BVAU.2429-43890
record_format oai_dc
spelling ndltd-LACETR-oai-collectionscanada.gc.ca-BVAU.2429-438902014-03-26T03:39:11Z An animal model of Burning Mouth Syndrome (BMS) for assessment of peripheral gamma-aminobutuyric acid A (GABAA) receptors as an analgesic target Tan, Sun Nee Burning Mouth Syndrome (BMS) is a chronic pain syndrome characterised by burning pain in patients with clinically normal oral mucosa (Grushka et al., 2002). The prevalence of BMS increases with age and occurs far more commonly in women, with estimated female to male ratios ranging from 3:1 to 16:1 (Grushka, 1987b, van der Ploeg et al., 1987, Clark G.T, 2005). In women, there is a strong correlation between the development of BMS and the onset of menopause (Lipton et al., 1993, Bergdahl and Bergdahl, 1999). A proposed theory is that deprivation of oestrogen produces atrophic changes within the oral epithelium (Valimaa et al., 2004) leading to symptoms of BMS. Therefore, I employed immunohistochemistry and electrophysiology techniques to test the hypotheses that ovariectomised rats will show reduced nerve fibre densities and lower proportions of peptidergic neuronal fibres (small-diameter fibres) in the tongues leading to reduced thermal and mechanical thresholds of afferent fibres. A non-conventional treatment for BMS that seems effective (Gremeau-Richard et al., 2004) is sucking a tablet of the benzodiazepine (BZD), clonazepam, without swallowing. This treatment is speculated to decrease pain by activating peripheral ɣ-aminobutyric acid receptors A (GABAA) receptors in the oral cavity. Expression of GABAA receptors in tongue afferent fibres has yet to be demonstrated. Also, evidence for a direct effect of BZDs on nociceptors in the oral mucosa is lacking. My hypotheses are: GABAA receptors are present on both peptidergic and non-peptidergic nerve fibres. Activation of peripheral GABAA receptors will increase mechanical thresholds of tongue nerve fibres which would explain the therapeutic efficacy of topical clonazepam in human BMS. This study found high proportions of GABAAʏ²- containing, peptidergic (94%) and GABAAʏ²-containing, non-peptidergic (93%) tongueaxonal fibres of intact female rats. In intact females, muscimol and ɣ-aminobutyric acid (GABA) solutions had no effect on relative mechanical thresholds of afferent fibres. After thermal stimulation, muscimol significantly increased relative mechanical thresholds of afferent fibres. Ovariectomised and sham-operated rats did not differ in any of the parameters measured. Topical applications of muscimol and bicuculline solutions did not have any significant effect on relative mechanical thresholds of nerve fibres in both rat groups. 2013-01-29T17:32:33Z 2013-01-29T17:32:33Z 2013 2013-01-29 2013-05 Electronic Thesis or Dissertation http://hdl.handle.net/2429/43890 eng http://creativecommons.org/licenses/by-nc-nd/3.0/ Attribution-NonCommercial 2.5 Canada University of British Columbia
collection NDLTD
language English
sources NDLTD
description Burning Mouth Syndrome (BMS) is a chronic pain syndrome characterised by burning pain in patients with clinically normal oral mucosa (Grushka et al., 2002). The prevalence of BMS increases with age and occurs far more commonly in women, with estimated female to male ratios ranging from 3:1 to 16:1 (Grushka, 1987b, van der Ploeg et al., 1987, Clark G.T, 2005). In women, there is a strong correlation between the development of BMS and the onset of menopause (Lipton et al., 1993, Bergdahl and Bergdahl, 1999). A proposed theory is that deprivation of oestrogen produces atrophic changes within the oral epithelium (Valimaa et al., 2004) leading to symptoms of BMS. Therefore, I employed immunohistochemistry and electrophysiology techniques to test the hypotheses that ovariectomised rats will show reduced nerve fibre densities and lower proportions of peptidergic neuronal fibres (small-diameter fibres) in the tongues leading to reduced thermal and mechanical thresholds of afferent fibres. A non-conventional treatment for BMS that seems effective (Gremeau-Richard et al., 2004) is sucking a tablet of the benzodiazepine (BZD), clonazepam, without swallowing. This treatment is speculated to decrease pain by activating peripheral ɣ-aminobutyric acid receptors A (GABAA) receptors in the oral cavity. Expression of GABAA receptors in tongue afferent fibres has yet to be demonstrated. Also, evidence for a direct effect of BZDs on nociceptors in the oral mucosa is lacking. My hypotheses are: GABAA receptors are present on both peptidergic and non-peptidergic nerve fibres. Activation of peripheral GABAA receptors will increase mechanical thresholds of tongue nerve fibres which would explain the therapeutic efficacy of topical clonazepam in human BMS. This study found high proportions of GABAAʏ²- containing, peptidergic (94%) and GABAAʏ²-containing, non-peptidergic (93%) tongueaxonal fibres of intact female rats. In intact females, muscimol and ɣ-aminobutyric acid (GABA) solutions had no effect on relative mechanical thresholds of afferent fibres. After thermal stimulation, muscimol significantly increased relative mechanical thresholds of afferent fibres. Ovariectomised and sham-operated rats did not differ in any of the parameters measured. Topical applications of muscimol and bicuculline solutions did not have any significant effect on relative mechanical thresholds of nerve fibres in both rat groups.
author Tan, Sun Nee
spellingShingle Tan, Sun Nee
An animal model of Burning Mouth Syndrome (BMS) for assessment of peripheral gamma-aminobutuyric acid A (GABAA) receptors as an analgesic target
author_facet Tan, Sun Nee
author_sort Tan, Sun Nee
title An animal model of Burning Mouth Syndrome (BMS) for assessment of peripheral gamma-aminobutuyric acid A (GABAA) receptors as an analgesic target
title_short An animal model of Burning Mouth Syndrome (BMS) for assessment of peripheral gamma-aminobutuyric acid A (GABAA) receptors as an analgesic target
title_full An animal model of Burning Mouth Syndrome (BMS) for assessment of peripheral gamma-aminobutuyric acid A (GABAA) receptors as an analgesic target
title_fullStr An animal model of Burning Mouth Syndrome (BMS) for assessment of peripheral gamma-aminobutuyric acid A (GABAA) receptors as an analgesic target
title_full_unstemmed An animal model of Burning Mouth Syndrome (BMS) for assessment of peripheral gamma-aminobutuyric acid A (GABAA) receptors as an analgesic target
title_sort animal model of burning mouth syndrome (bms) for assessment of peripheral gamma-aminobutuyric acid a (gabaa) receptors as an analgesic target
publisher University of British Columbia
publishDate 2013
url http://hdl.handle.net/2429/43890
work_keys_str_mv AT tansunnee ananimalmodelofburningmouthsyndromebmsforassessmentofperipheralgammaaminobutuyricacidagabaareceptorsasananalgesictarget
AT tansunnee animalmodelofburningmouthsyndromebmsforassessmentofperipheralgammaaminobutuyricacidagabaareceptorsasananalgesictarget
_version_ 1716656599554064384